In addition, the cytotoxic effect of imidazole and triazole derivatives was evaluated in prostate and breast cancer cell lines, observing selective effects over HO-1 or HO-2, consistent with an anti-proliferative capacity for HO inhibitors [109]. This evidence concerns the gene HMOX1 and breast carcinoma.